logo
logo
Search For Features
/
StocksStocks
Intraday BoosterIntraday Booster
Sector BoosterSector Booster
Stock ScreenerStock Screener
Market PulseMarket Pulse
ScreenersScreeners
MoreMore
prime iconGo Prime
My PlansMy Plans
Privacy PolicyPrivacy Policy
ContactContact
Refer & EarnRefer & Earn
ScreenersScreeners
Main
Stock ScreenerStock Screener
Create ScreenerCreate Screener
Explore ScreenersExplore Screeners
Community ScreenersCommunity Screeners
Trading Screeners
CandleSticks ScreenerCandleSticks Screener
Top Gainers & LosersTop Gainers & Losers
Opening Range BreakoutOpening Range Breakout
Stock Screener AIStock Screener AI
Stock Quality ScorecardStock Quality Scorecard
Overvalued StocksOvervalued StocksNew
Undervalued StocksUndervalued StocksNew
Technical Screeners
NR4 StocksNR4 Stocks
NR7 StocksNR7 Stocks
Previous Day High BreakoutPrevious Day High Breakout
Previous Day Low BreakoutPrevious Day Low Breakout
Previous Day Open BreakoutPrevious Day Open Breakout
Bullish Crossover StocksBullish Crossover Stocks
Bearish Crossover StocksBearish Crossover Stocks
High Volume ShockerHigh Volume Shocker
VWAP Breakout StocksVWAP Breakout Stocks
Range High BreakoutRange High Breakout
Range Low BreakoutRange Low Breakout
MoreMore
Markets
Global Market TodayGlobal Market Today
Global IndicesGlobal Indices
Indian IndicesIndian Indices
NIfty TodayNIfty Today
Smart Money
FII DII DataFII DII DataNew
FII BuyingFII Buying
NSE Insider TradingNSE Insider Trading
SLB Stocks DataSLB Stocks Data
Derivatives
FnO MovementsFnO Movements
NSE F&O Lot SizeNSE F&O Lot Size
Ban ListBan List
Analysis & Calendars
Technical DashboardTechnical Dashboard
Sector BoosterSector Booster
Sector AnalysisSector AnalysisNew
Result CalendarResult Calendar
Economic CalendarEconomic Calendar
Healthcare Global Enterprises Ltd

Healthcare Global Enterprises

Mid Cap•6,150 Employees•IPO 2016
Current Price
₹543.80
-16.5 (-2.94%)Updated
NSE :HCG
BSE :539787
Sector :Health Care Providers & Services
Today's Range
538.85
₹543.80
indicator
558.1
52 Week Range
52W Low₹491.00
52W High₹804.65
₹543.80
indicator
Downside10.75%
Upside47.97%
chart iconChart

Price Chart

Compare with Peers

Historical Ratios

Track top 12 most important financial ratios

P/E Ratio: Price to Earnings - Most used valuation metric

Loading chart...

Analyzing Investment Quality

Processing 9 key metrics...

Key Metrics

Hover for details

Valuation

Market Cap
₹8,156.59 Cr
Market Cap
Total market value of company
P/E Ratio
430.43
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)
P/B Ratio
9.85
P/B Ratio
Price to Book Value. <3 may indicate undervaluation
EPS
₹1.34
EPS
Earnings Per Share. Higher and growing is positive

Profitability

ROE
2.56%
ROE
Return on Equity. >15% is good, >20% is excellent
ROCE
8.56%
ROCE
Return on Capital Employed. >15% is good
Net Margin
0.77%
Net Margin
Net profit as % of revenue. >10% is good
Operating Margin
-%
Operating Margin
Operating profit margin. >15% is good

Growth

EPS Growth (5Y)
-%
EPS Growth (5Y)
5-year EPS growth. >15% is strong
Revenue Growth (5Y)
15.22%
Revenue Growth (5Y)
5-year revenue growth. >10% is good
Qtr Sales Growth
16.70%
Qtr Sales Growth
Quarter-over-quarter sales growth
Qtr Profit Growth
-60.70%
Qtr Profit Growth
Quarter-over-quarter profit growth

Financial Health

Debt/Equity
1.99
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellent
Book Value
₹66.16
Book Value
Net asset value per share
Dividend Yield
-%
Dividend Yield
Annual dividend as % of price. >2% is good
Promoter Holding
63.80%
Promoter Holding
Promoter stake. >50% shows confidence
Good
Average
Needs Attention

SWOT Analysis

Strengths

3 points
  • •Healthcare Global Enterprises Ltd. shows a healthy operating profit margin (OPM) of 17.50%, reflecting efficient operations and cost management. This strong OPM highlights the company's ability to generate profits from its core business activities.
  • •Despite recent profit fluctuations, HCG exhibits positive sales growth, with a 16.7% increase in quarterly sales. This growth signals strong underlying demand for its services and potential for future profitability improvements.

Weaknesses

6 points
  • •HCG's high debt-to-equity ratio of 1.99 indicates substantial reliance on debt, increasing financial vulnerability. This elevated leverage poses a significant risk, particularly during economic downturns or periods of reduced profitability.
  • •The company's return on equity (ROE) of 5.14% is relatively low compared to industry averages, indicating inefficient use of equity capital. This low ROE suggests that the company may need to improve its capital allocation strategies.

Opportunities

3 points
  • •The growing demand in the healthcare sector, driven by an aging population, increased health awareness, and medical tourism, presents significant expansion opportunities for HCG's specialized services.
  • •Potential for geographical expansion into underserved regions or diversification into complementary healthcare services could unlock new revenue streams and enhance HCG's market presence.

Threats

4 points
  • •Intense competition from established and emerging players in the hospital sector, as evidenced by strong peers, could pressure HCG's market share and profitability margins.
  • •Strict and evolving healthcare regulations, including pricing controls or quality standards, pose a continuous compliance burden and could impact HCG's operational flexibility and costs.

Segment-wise Financial Analysis

Fetching Financials...
Fetching Balance Sheet...
Fetching Cash Flow...

Shareholding Pattern

Loading shareholding data...

Company Insider Trading Activity

Recent Insider Transactions

Insider NameTransaction DateFiling DateTotal SharesChangePriceAction
Dr Navin Chugh
14 Feb 202517 Feb 20252,400
300
₹10BUY
Roshan
14 Feb 202517 Feb 2025525
525
₹10BUY
Dr Aditya Kaura
14 Feb 202517 Feb 20255,250
600
₹10BUY
Ashwini P K
14 Feb 202517 Feb 20254,125
375
₹10BUY
Yuva Kishore Terli
14 Feb 202517 Feb 20251,125
225
₹10BUY
Asha Nagaraj
14 Feb 202517 Feb 20258,300
150
₹10BUY
Vijay S Shanbhag
14 Feb 202517 Feb 20255,250
375
₹10BUY
Dr Amarjeet Singh
14 Feb 202517 Feb 20252,625
375
₹10BUY
Lakshman T L
14 Feb 202517 Feb 20257,670
600
₹10BUY
Prateek Jain
14 Feb 202517 Feb 20259,411
1,087
₹10BUY
Narayanan V
14 Feb 202517 Feb 202516,300
450
₹10BUY
BOMANAHALLI RANGASWAMAIAH GIRISH
14 Feb 202517 Feb 20257,700
150
₹10BUY
Ashutosh Kumar
14 Feb 202517 Feb 20255,000
5,000
₹10BUY
Lakshman T L
05 Mar 202507 Mar 20255,070
2,000
₹514SELL
BOMANAHALLI RANGASWAMAIAH GIRISH
04 Mar 202507 Mar 20255,550
2,000
₹512SELL
Venkataramanan P
13 Mar 202514 Mar 202534,492
723
₹505SELL
Venkataramanan P
12 Mar 202514 Mar 202535,215
5,621
₹508.06SELL
Dr B S Ajaikumar
12 Mar 202514 Mar 20251.45 Cr
18.93 L
₹500BUY
Madan Kumar Sampath
11 Mar 202514 Mar 2025-
3,050
₹507SELL
Venkataramanan P
19 Mar 202520 Mar 202518,492
16,000
₹503.99SELL
Venkataramanan P
20 Mar 202521 Mar 202514,414
4,078
₹503.61SELL
BOMANAHALLI RANGASWAMAIAH GIRISH
24 Mar 202524 Mar 20253,700
2,000
₹534SELL
Ashutosh Kumar
21 Mar 202524 Mar 2025-
5,000
₹519.58SELL
Venkataramanan P
21 Mar 202524 Mar 20251,414
13,000
₹503.01SELL
Sudeep Dey
28 Mar 202501 Apr 2025550
14,000
₹535SELL
ACESO COMPANY PTE LTD
30 May 202502 Jun 20251.22 Cr
7.19 Cr
₹445SELL

Corporate Action

Company Announcements

Technical Analysis & Indicators

Standard pivot points - most widely used

Pivot Points (CLASSIC)

LevelPriceDistance% Change
R4₹593.48+₹49.68+9.14%
R3₹574.23+₹30.43+5.60%
R2₹566.17+₹22.37+4.11%
R1₹554.98+₹11.18+2.06%
PIVOT₹546.923.120.57%
CURRENT₹543.80--
S1₹497.23-₹46.57-8.56%
S2₹516.48-₹27.32-5.02%
S3₹527.67-₹16.13-2.97%
S4₹535.73-₹8.07-1.48%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: N/AP: N/ATC: N/A
R1
R2
R3
R4
indicator
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment

is trading CPR, indicating

● CPR Width

CPR is

● Opening Range

Day's range: ~

● Price Position

Trading Inside opening range

Delivery Volume Analysis & Trading Activity

Latest Volume
1.29L
(13 Mar 2026)
-19.3% vs avg
Delivery %
60.6%
(13 Mar 2026)
+3.5% vs avg
Avg Volume (20D)
1.60L
(13 Feb - 13 Mar)
20-day average
Avg Delivery %
57.0%
(13 Feb - 13 Mar)
Trend ↑
Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.

Peer Comparison & Industry Benchmarking

Quick Compare

Largest by Market Cap
Apollo Hospitals Enterprise Ltd
1.09L ₹ Cr
Best Profit Growth
Dr Agarwals Health Care Ltd
151.00 %
Highest Dividend Yield
Indraprastha Medical Corporation Ltd
1.13 %

Peer Comparison

Company Name
AGARWALEYE
Dr Agarwals Health Care Ltd
APOLLOHOSP
Apollo Hospitals Enterprise Ltd
ARTEMISMED
Artemis Medicare Services Ltd
ASTERDM
Aster DM Healthcare Ltd
INDRAMEDCO
Indraprastha Medical Corporation Ltd
JLHL
Jupiter Life Line Hospitals Ltd
JSLL
KIMS
Krishna Institute of Medical Sciences Ltd
MEDANTA
Global Health Ltd
RAINBOW
Rainbow Childrens Medicare Ltd
SHALBY
Shalby Ltd
YATHARTH
Yatharth Hospital & Trauma Care Services Ltd

About

HCG

Healthcare Global Enterprises Ltd

HealthCare Global Enterprises Limited (HCG) is a leading provider of medical and healthcare services in India and internationally, specializing primarily in cancer care and fertility treatments. Their core business model revolves around delivering high-quality medical services across a range of specialties, with a significant focus on these two key areas.

In the realm of cancer care, HCG offers a comprehensive suite of diagnostic and treatment services. This includes radiation therapy, medical oncology (chemotherapy and other medical treatments), and surgical oncology. They also incorporate laboratory services and actively engage in research and development to improve cancer diagnosis, prognosis, and treatment outcomes. This integrated approach aims to provide patients with a holistic and advanced cancer care experience.

HCG's fertility services operate under the Milann brand, a well-established name in the field of reproductive medicine. Milann provides a wide spectrum of treatments, ranging from assisted reproductive technologies (ART) like in-vitro fertilization (IVF) to gynecological endoscopy and fertility preservation services. This comprehensive approach caters to a diverse range of patients' needs within the fertility space.

Beyond cancer and fertility, HCG operates multi-specialty hospitals under the HCG brand. These hospitals provide both inpatient and outpatient services covering a broad array of medical specialties, including cardiology, neurology, orthopedics, gastroenterology, urology, internal medicine, pulmonology, and critical care. This diversification allows HCG to offer a wider range of services and potentially attract a larger patient base.

In summary, HCG's business strategy combines specialized expertise in cancer and fertility with a broader multi-specialty hospital network. This diversified approach allows them to cater to a large and diverse patient population across multiple medical needs while maintaining a strong focus on advanced technologies and research to deliver high-quality medical care. Their integrated approach, spanning diagnostics, treatment, and research, positions them as a significant player within the Indian healthcare landscape and beyond.

COMPANY FACTS - HCG

Registered Address

Hcg Tower, No. 8, P. Kalinga Rao Road, Sampangi Rama Nagar

Bangalore

KARNATAKA

IN

Tel: 918046607700

Website:https://hcgel.com/

Investor Relations:https://hcgel.com/investors/
Company Details

Group: Health Care Equipment & Services

Sector: Health Care

Industry: Health Care Providers & Services

Exchange: NATIONAL STOCK EXCHANGE OF INDIA

Employees: 6,150

IPO Date: 30/03/2016

MANAGEMENT - HCG

Dr. Basavalinga Ajaikumar

Non-Independent Non-Executive Chairman of the Board

Dr. Manish Mattoo

Chief Executive Officer, Executive Director

Ms. Sunu Manuel

Compliance Officer, Company Secretary

Ms. Simrun Mehta

Non-Executive Non-Independent Director

Ms. Anjali Rossi

Non-Executive Non-Independent Director

Mr. Akshay Tanna

Non-Executive Non-Independent Director

Mr. Pradip Kanakia

Non-Executive Independent Director

Mr. Bijou Kurien

Additional Non-Executive Independent Director

Mr. Rajiv Maliwal

Non-Executive Independent Director

Ms. Geeta Mathur

Non-Executive Independent Director

Mr. Rajagoplan Raghavan

Non-Executive Independent Director

Investor Questions Answered

Healthcare Global Enterprises Ltd (HCG) Stock FAQs

Get answers to the most common questions about Healthcare Global Enterprises Ltd stock price, fundamentals, financial metrics, and investment analysis

The current share price of Healthcare Global Enterprises Ltd (HCG) is ₹543.8. Today, the stock has declined by ₹16.50 (2.94%), trading in a range of ₹538.85 to ₹558.1. The stock opened at ₹557 with a trading volume of 1,29,003 shares.
Healthcare Global Enterprises Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹8,156.59 crores, P/E ratio of 430.43, ROE of 2.56%, and ROCE of 8.56%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Healthcare Global Enterprises Ltd (HCG) is ₹804.65, while the 52-week low is ₹491. Currently trading at ₹543.8, the stock is 16.8% away from its 52-week low and 32.4% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Healthcare Global Enterprises Ltd stock at ₹543.8 depends on multiple factors. The stock is currently trading with a P/E ratio of 430.43 and P/B ratio of N/A. Today's performance shows a loss of 2.94%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Healthcare Global Enterprises Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹543.8, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Healthcare Global Enterprises Ltd's key financial metrics include: P/E Ratio: 430.43, P/B Ratio: N/A, ROE: 2.56%, ROCE: 8.56%, Dividend Yield: 0.00%, EPS: ₹1.34, Book Value: ₹66.16, Debt-to-Equity: 1.99, and Current Ratio: N/A. The company's market cap stands at ₹8,156.59 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Healthcare Global Enterprises Ltd stock opened at ₹557 and is currently trading at ₹543.8, showing a decline of ₹16.50 (2.94%). The intraday high is ₹558.1 and low is ₹538.85. The trading volume stands at 1,29,003 shares, indicating moderate market participation today.
Healthcare Global Enterprises Ltd has a Price-to-Earnings (P/E) ratio of 430.43, which means investors are willing to pay ₹430.43 for every ₹1 of earnings. With an EPS of ₹1.34, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
Healthcare Global Enterprises Ltd has a market capitalization of ₹8,156.59 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹543.8) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Healthcare Global Enterprises Ltd has a book value of ₹66.16 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹543.8, which is 721.9% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Healthcare Global Enterprises Ltd has a Return on Equity (ROE) of 2.56% and Return on Capital Employed (ROCE) of 8.56%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
Healthcare Global Enterprises Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Healthcare Global Enterprises Ltd has a debt-to-equity ratio of 1.99, which measures the company's financial leverage by comparing total debt to shareholders' equity. A ratio above 1 suggests the company uses more debt than equity for financing. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Healthcare Global Enterprises Ltd has an Earnings Per Share (EPS) of ₹1.34, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹543.8 and P/E ratio of 430.43, investors are paying 430.43 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
Healthcare Global Enterprises Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Healthcare Global Enterprises Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Healthcare Global Enterprises Ltd stock, consider: 1) Fundamental Analysis - Review P/E (430.43), ROE (2.56%), debt-to-equity (1.99), and growth rates. 2) Technical Analysis - Check 52-week range (₹491.00 - ₹804.65), moving averages, and chart patterns. 3) Valuation - Compare current price (₹543.80) with book value (₹66.16) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Healthcare Global Enterprises Ltd share is ₹10.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹543.8 is 5338x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Healthcare Global Enterprises Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹491.00 - ₹804.65). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 1.99 indicates leverage. 4) Liquidity Risk - Based on trading volume of 1,29,003 shares. 5) Valuation Risk - P/E of 430.43 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Healthcare Global Enterprises Ltd operates in the industry with key metrics: P/E ratio of 430.43, ROE of 2.56%, market cap of ₹8,156.59 crores, and dividend yield of 0.00%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 1.99), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Healthcare Global Enterprises Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹543.8, with a 52-week range of ₹491.00 to ₹804.65. Based on fundamentals like P/E (430.43), ROE (2.56%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Healthcare Global Enterprises Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹543.80. 2) Fundamental Deterioration - Declining ROE (currently 2.56%), increasing debt (D/E: 1.99), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Healthcare Global Enterprises Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.00%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.